It is known that limitations in PC synthesis result in enlarged LDs (5, 39), which is a common phenotype, described histopathologically as macrosteatosis, in NAFLD (3), raising the hypothesis that specific LPCs transported by Mfsd2a might function to drive LD biogenesis. This evidence concerns the gene MFSD2A and metabolic dysfunction-associated steatotic liver disease.